{"id":"W2065235857","doi":"10.1111/apt.12499","title":"Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from <scp>CHARM</scp> and <scp>ADHERE</scp>","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Relypsa; Takeda Oncology; Merck Sharp and Dohme; Genentech; Norgine; Astellas Pharma; Eisai; Ironwood Pharmaceuticals, Incorporated; Therakos; AbbVie; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; Procter and Gamble; Atlantic Healthcare; Amgen; ActoGeniX; Sanofi; Otsuka America; Celgene; Pfizer; Biogen; GlaxoSmithKline; Tillotts Pharma; Shire; Orexigen Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Adalimumab; Medicine; Crohn's disease; Adverse effect; Internal medicine; Clinical endpoint; Surgery; Maintenance therapy; Clinical trial; Gastroenterology; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001255691,0.000344486,0.0003132783,0.00008522,0.00006737908,0.00001938359,0.0005307082,0.0001698838,0.0002768923],"category_scores_gemma":[0.000005179909,0.0003452498,0.0001110319,0.00008682332,0.0002693286,0.00003102849,0.0005538322,0.0001069451,0.00005020485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005904882,"about_ca_system_score_gemma":0.0001892471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001953315,"about_ca_topic_score_gemma":0.00002493746,"domain_scores_codex":[0.9980065,0.000245944,0.0004364215,0.0006829288,0.000183895,0.0004443281],"domain_scores_gemma":[0.9982522,0.0001351813,0.0002082149,0.0008682344,0.00009916312,0.0004370701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0006842716,0.0005490191,0.04519891,0.00005857344,0.004836252,0.0002191521,0.0008882566,0.00003496566,0.9350513,0.000004446594,0.01038466,0.002090187],"study_design_scores_gemma":[0.006073783,0.0008528029,0.5648303,0.00005351039,0.00629998,0.000007964648,0.001099239,0.000697443,0.3589465,0.000235016,0.06067802,0.0002254231],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943701,0.002602292,0.00003099047,0.0001553796,0.0003796644,0.0008647771,0.001508771,0.00001919502,0.00006880899],"genre_scores_gemma":[0.9910254,0.001567574,0.0003652821,0.004831025,0.000233629,0.0001181989,0.00115626,0.00006573991,0.0006369133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5761048,"threshold_uncertainty_score":0.9998999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0230151932692611,"score_gpt":0.2933277874489523,"score_spread":0.2703125941796912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}